Skip to main content
Clinical Trials/NCT02346448
NCT02346448UnknownNot Applicable

Endoscopic Sphincterotomy vs. Balloon Dilation for Assessment of Pancreatitis: A Prospective Randomized Multicenter Trial

Helios Albert-Schweitzer-Klinik Northeim6 sites in 1 country600 target enrollmentStarted: February 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
600
Locations
6
Primary Endpoint
acute pancreatitis

Study Overview

Brief Summary

One of the major elements of successful endoscopic retrograde cholangiopancreatography ( ERCP) is the timely and uncomplicated cannulation of the common bile duct (CBD) . Various factors may adversely affect the cannulation procedure of the CBD leading to complications (acute pancreatitis after ERCP, perforation of the duodenum , bleeding ). Endoscopic sphincterotomy is frequently required for interventional procedures (eg stone extraction). During sphincterotomy, incision of the orifice of the papilla will be performed by using a sphincterotome. Complications due to sphincterotomy are known: Bleeding, increased rates of acute pancreatitis, small bowel perforation and scarring with consecutive stenosis of the papilla. As an alternative to sphincterotomy, balloon dilatation using balloon catheters can be performed. As a result, bleeding complications and scarring as late effects might be prevented. Current data is limited in terms of the risk of acute pancreatitis after ERCP when using a balloon catheter.

This study aims to evaluate the incidence of acute pancreatitis and other complications after ERCP. Balloon dilatation of the papilla will be prospectively compared with endoscopic sphincterotomy in a randomized multicenter setting.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • independent indication for ERCP
  • age ≥ 18 years
  • patient is able to understand informed consent

Exclusion Criteria

  • S/p sphincterotomy
  • pancreatic or CBD-stent in situ
  • pregnant patient
  • known chronic pancreatitis
  • acute pancreatitis prior to intervention

Arms & Interventions

endoscopic sphincterotomy

Active Comparator

performing endoscopic sphincterotomy of papilla of Vater during ERCP Device: standard sphincterotome

Intervention: endoscopic sphincterotomy (Procedure)

balloon dilatation for 3 minutes

Active Comparator

Balloon dilatation of papilla of Vater for 3 minutes during ERCP using 10mm balloon Device: standard dilation balloon catheter (10mm size)

Intervention: balloon dilatation for 3 minutes (Procedure)

balloon dilatation for 6 minutes

Active Comparator

Balloon dilatation of papilla of Vater for 6 minutes during ERCP using 10mm balloon Device: standard dilation balloon catheter (10 mm size)

Intervention: balloon dilatation for 6 minutes (Procedure)

Outcomes

Primary Outcomes

acute pancreatitis

Time Frame: one to 10 days

Definition of acute pancreatitis: Serum lipase or amylase obtained 2 to 6 hours following ERCP + onset of abdominal pain after ERCP persisting for 24h+ need for analgesia

Secondary Outcomes

  • severity of pancreatitis using the Imrie score system (according to Imrie et al.)(one to 10 days)
  • endoscopic perforation(one to two days)
  • major bleeding(one to two days)

Investigators

Sponsor
Helios Albert-Schweitzer-Klinik Northeim
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (6)

Loading locations...

Similar Trials

Endoscopic Sphincterotomy vs. Balloon... | Clinical Trial